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The purpose of this article is to study one of the most signiﬁcant causes of neonatal morbidity and mortality:
neonatal sepsis. This pathology is due to a bacterial or fungal infection acquired during the perinatal period.
Neonatal sepsis has been categorized into two groups: early onset if it occurs within 3–6 days and late onset
after 4–7 days. Due to the not-speciﬁc clinical signs, along with the inaccuracy of available biomarkers, the
diagnosis is still a major challenge. In this regard, the use of a combined approach based on both nuclear
magnetic resonance (1H-NMR) and gas-chromatography-mass spectrometry (GC-MS) techniques, coupled
with a multivariate statistical analysis, may help to uncover features of the disease that are still hidden. The
objective of our study was to evaluate the capability of the metabolomics approach to identify a potential
metabolic proﬁle related to the neonatal septic condition. The study population included 25 neonates (15
males and 10 females): 9 (6 males and 3 females) patients had a diagnosis of sepsis and 16 were healthy
controls (9 males and 7 females). This study showed a unique metabolic proﬁle of the patients affected by
sepsis compared to non-affected ones with a statistically signiﬁcant difference between the two groups (p =
0.05).
© 2014 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Sepsis is a dysfunction affecting different organs caused by in-
fectious microorganisms and induced by mediators of inﬂammation
that cause alteration of the immune, inﬂammatory and coagulative
equilibrium. Sepsis is divided into early onset sepsis (EOS), which
takes place in the ﬁrst 72 hours (according to some authors within
the ﬁrst week of life) and late onset sepsis (LOS), which begins
after 72 hours and is usually caused by nosocomial pathogens [1].
In the United States, the incidence of early onset sepsis, assessed
in two different studies (Centers for Disease Control and Prevention
and National Institutes for Child Health and Development) was in
both studies approximately 3300 cases with 400 deaths per year
[2]. Moreover, the rates of infection and mortality increase with
the decrease in gestational age and birth weight. The most com-
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mon etiologies of EOS are E. coli and group B streptococcus (GBS)
(∼23% and 47% of cases, respectively). For LOS, coagulase-negative
staphylococci have emerged as major pathogens causing 39% of
cases. E. coli, S. aureus, Enterococcus spp. and GBS are important
pathogens during the neonatal period, although there is wide re-
gional variability. However, during the neonatal period, Klebsiella
spp., Enterobacter spp., P. aeruginosa and S. marcescens emerge as
etiologies of LOS which are rare pathogens within seven days of life
[3,4]. Worldwide, neonatal sepses are the cause of approximately
36% of the four million deaths of neonates every year. Neonatal
sepsis onsets in a subtle way and clinical signs at the beginning
may be vague and aspeciﬁc (not looking well, not eating well, not
breathing well). Early diagnosis is a challenge to pediatricians and
for this reason in the last few decades several studies have been
conducted in an attempt to ﬁnd a test that satisﬁes the criteria
to make it the ideal marker for EOS in the neonate. In this ﬁeld,
metabolomics appears to be quite promising [5]. Recent studies
show the eﬃcacy of this method in providing signiﬁcant informa-
tion leading to an early diagnosis of numerous neonatal pathologies
[6]. Metabolomics is a holistic approach that studies the complete
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set of low-molecular-weight metabolites contained in human body
ﬂuids [6]. The analysis of the metabolic proﬁle observable in a
body ﬂuid allows the immediate identiﬁcation of changes in the
composition of endogenous and exogenous metabolites that may
be correlated with speciﬁc pathophysiological states, gene expres-
sion and interaction with the environment [7]. To date, very few
publications have dealt with metabolomics and sepsis in adults and
children [8] and none in neonates. In our work we performed a
metabolomic analysis to assess variations of metabolites preceding
the onset of early and late sepsis in neonates for the purpose of
identifying a metabolic state leading to the onset of infection.
2. Materials and methods
2.1. Patients
This study was carried out on urine samples from two groups
of patients admitted to the four centers participating: the Neonatal
Intensive Care Unit (NICU) of the University of Cagliari, the NICU of
the San Matteo General Hospital (Pavia), the NICU of the University
of Palermo and Department of Maternal, Fetal and Neonatal Health
in the C. Arrigo Children’s Hospital (Alessandria). The single ethical
committees approved the study protocol and written informed
consent was obtained from the parents before enrolment in the
study. The ﬁrst group consisted of 9 newborns (6 males and 3
females with mean gestational age 29.1 weeks) who had received
a diagnosis of sepsis and the second group consisted of 16 healthy
controls (9 males and 7 females with mean gestational age 34.6
weeks). Among the septic patients, there were 5 cases of EOS (4
males and 1 female), with a mean age of 2.4 days at the time of
infection and 4 cases of LOS (2 males and 2 females) with a mean
age of 12.2 days at the time of infection. All newborns analyzed
in this experimental protocol have survived. The clinical data of
each patient were recorded in the hospital registers. Urine samples
(2–3 mL) were collected at birth and at regular intervals during
the ﬁrst month of life, then aspired with a syringe and transferred
to a sterile 15 ml Falcon tube. Due to a low volume of urine,
NMR evaluations were performed only in 14 healthy controls and
7 septic newborns (2 EOS, 5 LOS). The tubes were then split in
two vials containing 10 μL of a solution of sodium azide (NaN3) to
prevent bacterial contamination and then stored at −80°C awaiting
the metabolomic analysis.
2.2. Metabolomic analysis
2.2.1. Reagents
All chemicals used in this study were of analytical grade.
Dodecane was used as internal standard and pyridine and hexane
were used as a solvent (Sigma, St. Louis, MO, USA). Methoxy-
aminehydrochloride, N,O-bis(trimethylsilyl)triﬂuoroacetamide and
trimethylchlorosilane (BSTFA+TMCS) and urease were purchased
from Sigma (St. Louis, MO, USA). Deuterium oxide (D2O, 99.9%)
was purchased from Cambridge Isotope Laboratories Inc. (Andover,
MA, USA). Sodium 3-trimethylsilyl-propionate-2,2,3,3,-d4 (TSP, 98
atom% D) was acquired from Sigma-Aldrich (Milan, Italy).
2.2.2. GC-MS urine sample preparation
After thawing the urine samples on ice, they were centrifuged
for 10 minutes at 14000 rpm then 150 μL of supernatant were
transferred into an Eppendorf tube containing 1 mg of urease.
Samples were sonicated for 30 minutes at 37°C and then centrifuged
for 10 minutes at 13200 rpm. The supernatant was separated and
dried under nitrogen overnight and was derivatizated with 50 μL
of a solution of methoxyamine in pyridine (10 mg/mL). After 17
h 100 μL of BSTFA+TMCS was added and after 1 h samples were
resuspended with 600 μL of hexane containing dodecane at 5 mg/L.
2.2.3. GC-MS analysis
One microliter of derivatized sample was injected splitless into
a 6850 gas chromatograph coupled with a 5973 Network mass
spectrometer (Agilent Technologies, Santa Clara, CA, USA) equipped
with a 30 m ×0.25 mm ID, fused silica capillary column, which
was chemically bonded with 0.25 μm DB5-MS stationary phase
(J&W scientiﬁc, Folsom, CA, USA). The injector temperature was
200°C. The gas ﬂow rate through the column was 1 mL/min.
The column initial temperature was kept at 50°C for 10 min.
Then the temperature was increased from 50 to 300 at 10°C/min
and held at 300°C for 10 minutes. The transfer line and the ion
source temperatures were respectively 280°C and 180°C. Ions were
generated at 70 eV with electron ionization and were recorded
at 1.6 scan/sec over the mass range m/z 50–550. GC-MS data
analysis was conducted by integrating each resolved chromatogram
peak and normalizing the area for the corrected total area of the
chromatogram. These peaks were examined for their mass spectra
and identiﬁcation of the peaks was attempted using the NIST08
library after deconvolution with AMDIS.
2.2.4. NMR urine sample preparation
Samples of 1 mL of thawed urine were centrifuged at 12,000
rpm/min for 10 minutes at 4°C. An aliquot of 630 μl was then
withdrawn from the supernatant and 70 μl of a 1.5 M phosphate
buffer solution pH 7.4 with a ﬁnal concentration of 1 mM TSP
(trimethylsilyl propanoic acid) was added. Each sample was stirred
for 60 seconds and transferred into a 5 mm NMR tube for analysis.
2.2.5. NMR analysis
The spectra were acquired at 499,839 MHz using a Varian Unity
Inova 500 MHz spectrometer. The experiments were carried out
using a standard temperature of 27°C, a 1D NOESY sequence with a
90° pulse of 10.4 ms, an acquisition time of 2 s, 128 transients with
a spectral width of 6000 Hz. Once the spectra were acquired, phase
and baseline corrections were performed (Version 7.1.2, Mestrelab
Research S.L.). Afterwards, the 1H-NMR spectra were reduced to
consecutive integrated spectral regions (bins) of equal width (0.04
ppm) corresponding to the region 0.5–9.5 ppm. The spectral region
between 4.70–5.14 and 5.50–6.00 were excluded from the analysis
to remove the effect of variations in the presaturation of the
residual water and urea resonances. Bucketing was performed by
MestReNova. The integrated area within each bin was normalized to
a constant sum of 100 for each spectrum to minimize the effects of
variable concentration among different samples. The ﬁnal data set
was imported into the SIMCA-P+ program (Version 13.0, Umetrics,
Umeå, Sweden).
2.2.6. Statistical approaches
An orthogonal partial least square discriminant analysis (OPLS-
DA) of GC-MS and NMR data was performed using the SIMCA
software package (version 13.0, Umetrics, Umea, Sweden). OPLS-DA
is a data visualization method that is useful for observing group-
ing within multivariate data. This supervised analysis uses linear
regression, where the class memberships of samples are included
in the calculation. OPLS is able to rotate the projection so that the
model focuses on the effect of interest allowing a better distinction
between groups. The validity of the OPLS-DA model is assessed by
statistical parameters: the correlation coeﬃcient R2 and the cross-
validation correlation coeﬃcient Q2. R2 represent the accuracy of
the ﬁt to the model and Q2 reveals the grade of predictability of
the model. From a supervised analysis it is possible to obtain the
set of VIPs, “important variables on the projection”, the metabolic
variables that contribute to the characterization of groups.
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3. Results
GC-MS is considered the gold standard in metabolite detection
and quantiﬁcation; in fact, the sensitivity of MS is in the pico/nano
molar range, whilst proton nuclear magnetic resonance (1H-NMR)
spectroscopy is also considered a major tool for analyzing a
large number of molecules simultaneously with an analytical
sensitivity ranging 1–10 μmol/L. However, below this cutoff, the
detection and quantiﬁcation of metabolites is still unreliable. The
use of these techniques allows the identiﬁcation of different types
of metabolites depending on their concentration and chemical
structure; therefore, it may be appropriate to use both methods to
cover the largest number of molecules. The GC-MS coupled with
1H-NMR analysis showed important differences among neonates
with a septic condition compared to the controls. The metabolites
responsible for those differences were identiﬁed from the urine
samples collected at birth from the EOS group and within 72
hours prior the onset of infection for the LOS group. The resulting
ﬁngerprint may be considered a predictive tool of the septic
condition.
Fig. 1. GC/MS chromatograms of urine samples from (a) control and (b) septic subjects.
3.1. GC-MS
A comparison between the GC-MS chromatograms of urine
samples collected from control and septic newborns is shown in
Fig. 1 and the most important metabolites are reported in Table 1.
As it can be seen, there are signiﬁcant qualitative and quan-
titative differences between the two samples, the neonatal sepsis
Table 1
Urinary most relevant upregulated or downregulated metabolites in the septic
group, compared with the control group.
Compound tR (min) Trend
Lactate 15.58 ↑
Glucose 27.21 ↑
Maltose 34.58 ↑
Ribitol 25.29 ↓
Ribonic acid 25.92 ↓
Pseudo uridine 31.16 ↓
2,3,4-trihydroxybutyric acid 23.20 ↓
2-ketogluconic acid 25.81 ↓
3,4-dihydroxybutanoic acid 21.70 ↓
3,4,5-trihydroxypentanoic acid 24.51 ↓
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Fig. 2. OPLS-DA scores plot of control (ﬁlled circles) vs septic (shaded circles) urine samples.
chromatogram being characterized by peaks higher in number and
intensity with respect to those of controls.
The OPLS-DA analysis evidenced a clear separation between the
groups (Fig. 2). In fact, controls were homogenously located in the
left square of the plot, while septic samples were distributed in
the right square. To identify the variables (metabolites) separating
the two groups, the spectra data of the corresponding urine
samples were deconvoluted using AMDIS-NIST08, and the resulting
data were analyzed using an OPLS-DA classiﬁcation model. The
OPLS-DA model was generated with predictive components (T) and
orthogonal components (To) to discriminate between groups (sepsis
vs control) reﬂecting a high goodness of ﬁt and predictability as
indicated by an R2Y value of 0.96 and a Q2 value of 0.62,
respectively with a CV-ANOVA p-value of 0.003.
The analysis of the corresponding loading plot revealed variables
(i.e. metabolite retention times) of importance for the cluster-
ing, thus allowing the identiﬁcation of metabolites responsible
for the observed variance: metabolites located in the left part
were positively correlated with control samples, whereas those
located on the right were positively correlated with septic sam-
ples. The variables signiﬁcantly contributing to the separation of
the septic samples included several metabolites such as maltose
glucose and lactose, whereas control samples were characterized
by ribitol, ribonic acid, pseudouridine, 2,3,4-trihydroxybutyric acid
(THBA), 2-ketogluconic acid, 3,4-dihydroxybutanoic acid and 3,4,5-
trihydroxypentanoic acid.
3.2. NMR
A high-resolution 1H-NMR spectra comparison between the
urine samples collected from control and septic newborns is shown
in Fig. 3, and the dominant metabolites identiﬁed belonging to the
aliphatic and carbohydrate areas are also reported in Table 2. To be
noted is that few samples were not analyzed due to the paucity of
the sample. The assignment of major resonances was performed on
the basis of data published in the literature and using the Chenomx
database (Edmonton, Alberta, Canada).
In this case the OPLS-DA model was able to clearly differentiate
between neonatal sepsis and controls, reﬂecting a high goodness of
ﬁt and predictability as indicated by an R2Y value of 0.85 and a Q2
value of 0.43 respectively, with a CV-ANOVA p-value of 0.05 (Fig. 4).
The variables signiﬁcantly contributing to the separation of the
Table 2
1H-NMR chemical shift of the urinary most relevant metabolites identiﬁed in the
control and septic groups. The trend identiﬁes the behavior of septic newborns, in
comparison with controls.
Compound Group 1H (ppm) a 1H multiplicity b Trend
Acetate CH3 1.92 s ↑
Acetone CH3 2.24 s ↑
Citrate CH2 2.54 d ↓
CH2 2.67 d
Creatinine N-CH3 3.05 s ↓
N-CH2 4.06 s
Glycine CH2 3.57 s ↑
Lactate CH3 1.33 d ↑
CH 4.1 q
Lysine αCH 3.74 t
βCH2 1.89 m
γCH2 1.45 m ↑
δCH2 1.69 m
εCH2 3.01 t
Glucose C2H 3.23 3.52 dd
C3H,C6H 3.73 m
C5H 3.46 m
C4H 3.4 m ↑
C5H,C6H 3.82 m
C6H 3.88 dd
C1H 5.24 4.64 d
a 1H chemical shifts are reported with respect to TSP signal (0.00 ppm).
b Multiplicity deﬁnitions: s, singlet; s, doublet; t, triplet; dd, doublet of doublets;
m, multiplet.
septic samples included several metabolites such as acetate, glycine,
glucose, acetone, lactate and lysine, whereas control samples were
characterized by citrate and creatinine. The analysis of the corre-
sponding loading plot revealed variables (i.e. bins) of importance
for the clustering, thus allowing the identiﬁcation of metabolites
responsible for the observed variance: metabolites located in the
left part were positively correlated with control samples, whereas
those located on the right were positively correlated with septic
samples. The loadings corresponding to 3.4, 3.36, and 1.36 ppm
showed positive values, indicating that septic samples contained
relatively higher contents of glucose and lactate with respect to the
control group (Fig. 2b). On the contrary, control samples appeared
to be richer in citrate and creatinine (2.56, 4.08 ppm). Furthermore,
other bins, belonging to unidentiﬁed metabolites, were found
to be important for sample clustering (e.g., 1.16 belonging to
the pathological group). It is also worth noting that a deeper
S82 V. Fanos et al. / Early Human Development 90S1 (2014) S78–S83
Fig. 3. 1H-NMR spectra of urine samples from (a) control and (b) septic subjects with main assignments.
Fig. 4. OPLS-DA scores plot of control (ﬁlled circles) vs septic (shaded circles) urine samples.
examination of the score plot showed that EOS samples were
clustered with respect to the LOS samples. The relation between the
metabolic proﬁle of the EOS and the metabolic proﬁle of the LOS
groups was not possible because of the low number of samples.
4. Discussion
Although biomolecular knowledge on the pathophysiology of
neonatal sepsis has improved over the years, no markers making
early diagnosis possible have yet been identiﬁed, nor have prog-
nostic biomarkers of high sensitivity and speciﬁcity been found.
Several studies have shown that for every hour of delay in admin-
istration of an appropriate antibiotic therapy there is a 7% increase
in mortality [9]. The need for a highly sensitive and predictive
test in the neonatal period for identifying and correctly classifying
the maximum number of septic neonates makes metabolomics a
method of great diagnostic potential. To our knowledge, this is
the ﬁrst work described in the literature that has analyzed with
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metabolomics the urine metabolic proﬁles in septic neonates and
controls for the purpose of deﬁning the metabolic patterns asso-
ciated with this pathology. From the very ﬁrst analysis, performed
both with mass spectroscopy and NMR on urine samples of the
four participating centers, it was possible to identify by multivari-
ate analysis a different metabolomics pattern between classes of
neonates having a different clinical outcome (sepsis versus control).
From this proﬁle the septic neonates were signiﬁcantly separated
from controls. Moreover, the samples from EOS neonates were
separated from those of LOS (although overall the samples were too
few to arrive at a ﬁnal assessment) (Figs. 2 and 4). In this study,
metabolomics led to identifying the molecules responsible for the
differences in the metabolic proﬁles, among which glucose, lactate
and acetate, the urine content of which had increased in septic
neonates compared to controls, while THBA, ribitol, ribonic acid
and citrate had decreased. These results agree with recent works
published in the literature. In particular, in our study the presence
of acetone ketone bodies in the urine of the septic group suggests a
compensatory reaction to a reduced level of ATP. It is interesting to
see that also in works on metabolomics in the literature, conducted
both on animals and humans, there were increases in metabolites
(in plasma and urine) which are part of the oxidative metabolism
of fatty acids, such as the ketone bodies (hydroxybutyrate, ace-
toacetate), in septic subjects [8,10–12]. Lin et al. suggest that the
increase in acetoacetate and hydroxybutyrate in septic rats may be
correlated with major oxidation of fatty acids. As the major source
of energy, fatty acid oxidation is signiﬁcantly enhanced to meet the
energy requirement [13], and ketone bodies, which are important
products of fatty acid oxidation, increase and accumulate accord-
ingly [10]. Lactate and glucose were also found to have increased
in the urine of septic patients compared to controls both in our
study and other works [8,10,12,14] while citrate, a metabolite of the
Krebs cycle, had decreased. These results can be explained by taking
into account that sepsis corresponds to a systemic inﬂammation
associated with mechanisms such as hypoxia and oxidative stress.
Sepsis per se induces an impairment in energy production at the
cell level owing to the blocking of the pyruvate dehydrogenase
complex, the enzyme intimately involved in the production of
lactates from which depend access of pyruvate into the Krebs cycle
[15,16]. It is known that during septic shock there is an increase in
glucose turnover through glycolysis with an increase in the levels of
lactate of anaerobic production [17]. Brieﬂy stated, the alterations
in the glucose metabolism in acute critical conditions can be seen
as a redistribution of glucose consumption from the mitochondrial
oxidative phosphorylation to other metabolic pathways, such as the
production of lactate and the pentose phosphate pathway. In our
metabolomic study of the urine of septic neonates, this is conﬁrmed
by an increase in the levels of glucose and lactate and a decrease in
the metabolites of the pentose phosphate pathway such as THBA,
ribitol and ribonic acid. It is to be emphasized that the two methods
take a “photograph” of the phenomenon in a way that is only
partially superimposable, as 1H-NMR spectroscopy does not require
sample modiﬁcation and allows the simultaneous identiﬁcation of
hundreds of metabolites with an analytical sensitivity in the range
of 1–10 mmol/L. However, below this cut off, the detection and
quantiﬁcation of metabolites is still unreliable whilst GC/MS is also
considered the gold standard in metabolite detection and quantiﬁ-
cation; depending on the metabolite, the sensitivity of MS is in the
pico/nano molar range.
5. Conclusions
Present-day methods and procedures for the diagnosis of neona-
tal sepsis are hindered by low sensitivity and long response times.
They are not capable of meeting the need to proceed to with rapid,
timely and eﬃcacious therapeutic treatment. In this study, thanks
to metabolomics, it was possible to identify the metabolites re-
sponsible for the differences between septic neonates and controls:
for EOS neonates at the time of birth and for the LOS neonates
within 72 hours preceding the clinical onset. These biomarkers may
be considered as early and reliable predictors of neonatal sepsis
since the urine samples used were collected previous to the onset
of infection. The data emerging from this study suggest that in the
near future metabolomics will make possible to identify an early
metabolic proﬁle of sepsis and thus begin earlier, more targeted and
effective treatments. However, in the next few years these results
will have to be supported by further studies to increase the num-
bers of samples and thus arrive at a more complete and signiﬁcant
picture of the metabolic differences between septic neonates and
controls.
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